Sonnet BioTherapeutics Holdings, Inc.
SONN
$1.38
$0.00980.72%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -9.43M | -7.44M | -7.99M | -8.43M | -14.46M |
| Total Depreciation and Amortization | 85.30K | 83.10K | 81.00K | 79.00K | 77.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 625.80K | 615.40K | 605.00K | 392.40K | 401.00K |
| Change in Net Operating Assets | 292.20K | -1.87M | -2.70M | -5.14M | -4.54M |
| Cash from Operations | -8.43M | -8.61M | -10.00M | -13.10M | -18.52M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -12.00K | -12.00K | -182.00K | -182.00K | -443.30K |
| Cash from Investing | -12.00K | -12.00K | -182.00K | -182.00K | -443.30K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 0.00 | -700.00 | -700.00 |
| Issuance of Common Stock | 10.77M | 6.90M | 6.90M | 5.71M | 20.30M |
| Repurchase of Common Stock | -21.80K | -21.80K | -17.70K | -17.70K | -17.70K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -474.30K | -385.40K | -172.50K | -15.00K | -- |
| Cash from Financing | 10.28M | 6.50M | 6.71M | 5.68M | 20.28M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.84M | -2.12M | -3.47M | -7.60M | 1.32M |